You are here

  • Home
  • Archive
  • Volume 87, Issue 5
  • Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

Citation Tools

Article menu
Multiple sclerosis
Research paper
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Cohen JA, Khatri B, Barkhof F on behalf of the TRANSFORMS (TRial Assessing injectable interferoN vS. FTY720 Oral in RRMS) Study Group, et al
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study
Journal of Neurology, Neurosurgery & Psychiatry 2016;87:468-475.